Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04639726 · ClinicalTrials.gov registry record · NA

A Study to Evaluate the Effects of Pre-Meal Whey Protein Microgels Administration on Post-Prandial Glycemic Response.

A NA study of Dietary Supplement, sponsored by Société des Produits Nestlé (SPN).

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT04639726 is a NA study of Dietary Supplement that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 26 participants, below the 47-participant average among 5 other Dietary Supplement trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04639726, a NA study of Dietary Supplement, has completed, sponsored by Société des Produits Nestlé (SPN).

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

This is a mechanistic, randomized, investigator-blinded, placebo-controlled, single-center, crossover study designed to evaluate the effects of premeal administration of whey protein microgels compared to placebo on postprandial glycemia in patients with type 2 diabetes.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Whey Protein Micro Gel
  • OTHER Water without Whey Protein.

Study Locations (1)

California

  • Orange County Research Center - Tustin

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2020-09-28
Est. Completion 2020-10-26
Phase NA

What the Registry Record Tells You About NCT04639726

The ClinicalTrials.gov registry entry for NCT04639726 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47-participant average among 5 other Dietary Supplement trials with a reported enrollment target (45% lower). The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dietary Supplement appearing as the primary indexed condition, and to 2 interventions - of which Whey Protein Micro Gel is the first listed.

NCT04639726 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04639726 about?

NCT04639726 is a clinical study titled "A Study to Evaluate the Effects of Pre-Meal Whey Protein Microgels Administration on Post-Prandial Glycemic Response.". This is a mechanistic, randomized, investigator-blinded, placebo-controlled, single-center, crossover study designed to evaluate the effects of premeal administration of whey protein microgels compared to placebo on postprandial glycemia in patients with type 2 diabetes.

What is the current status of trial NCT04639726?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-09-28. Estimated completion is 2020-10-26.

What conditions does trial NCT04639726 study?

This clinical trial studies the following conditions: Dietary Supplement.

What interventions are being tested in trial NCT04639726?

The interventions under investigation include: Whey Protein Micro Gel (DIETARY_SUPPLEMENT), Water without Whey Protein. (OTHER).

Who is sponsoring clinical trial NCT04639726?

This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04639726 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dietary Supplement

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.